Prevalence of anti-HCV positivity in hemodialysis patients [4]
dc.contributor.author | Sivrel Arisoy A. | |
dc.contributor.author | Kursat S. | |
dc.contributor.author | Gazi H. | |
dc.contributor.author | Kurutepe S. | |
dc.contributor.author | Ozbakkaloglu B. | |
dc.date.accessioned | 2024-07-22T08:25:39Z | |
dc.date.available | 2024-07-22T08:25:39Z | |
dc.date.issued | 2000 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.issn | 00282766 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20530 | |
dc.language.iso | English | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Antibodies, Viral | |
dc.subject | Female | |
dc.subject | Hepatitis C | |
dc.subject | Humans | |
dc.subject | Kidney Failure, Chronic | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Renal Dialysis | |
dc.subject | Seroepidemiologic Studies | |
dc.subject | hepatitis C antibody | |
dc.subject | recombinant erythropoietin | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | antibody detection | |
dc.subject | blood donor | |
dc.subject | blood transfusion | |
dc.subject | contamination | |
dc.subject | continuous ambulatory peritoneal dialysis | |
dc.subject | controlled study | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | female | |
dc.subject | hemodialysis patient | |
dc.subject | hepatitis C | |
dc.subject | high risk patient | |
dc.subject | human | |
dc.subject | letter | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | priority journal | |
dc.subject | seroprevalence | |
dc.subject | virus transmission | |
dc.title | Prevalence of anti-HCV positivity in hemodialysis patients [4] | |
dc.type | Letter |